Log in
Enquire now
‌

US Patent 10004725 Methods of treatment

Patent 10004725 was granted and assigned to Global Blood Therapeutics on June, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Global Blood Therapeutics
Global Blood Therapeutics
Date Filed
March 29, 2016
Date of Patent
June 26, 2018
Patent Applicant
Global Blood Therapeutics
Global Blood Therapeutics
Patent Application Number
15084252
Patent Citations Received
‌
US Patent 11944612 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1H-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
0
‌
US Patent 11071725 Activating pyruvate kinase R
‌
US Patent 11649242 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
0
‌
US Patent 11396513 Compositions for activating pyruvate kinase
‌
US Patent 10683285 Modulators of hemoglobin
‌
US Patent 11548880 Modulators of hemoglobin
‌
US Patent 11001588 Activating pyruvate kinase R and mutants thereof
‌
US Patent 11014884 Modulators of hemoglobin
‌
US Patent 11014927 Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators
‌
US Patent 11020382 Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10004725
Patent Primary Examiner
‌
Jennifer M Kim

Find more entities like US Patent 10004725 Methods of treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.